How Much Melatonin Does It Take to Kill You?

No confirmed lethal dose of melatonin has been established in adults. Despite widespread availability and rising use, there is no published threshold at which melatonin reliably kills an adult human, and researchers who have reviewed the toxicology literature describe it as one of the least toxic substances available over the counter. That does not mean massive doses are harmless, though. A handful of deaths have occurred in children, drug interactions can cause serious organ stress, and the supplement industry’s quality control makes it surprisingly hard to know how much you are actually swallowing.

What the Toxicology Evidence Shows

The reason there is no established adult lethal dose is partly practical: almost nobody dies from melatonin alone, so the data points to build a lethal-dose model barely exist. One forensic case report documented adult blood melatonin concentrations of 3.9 and 4.4 mg/L in a deceased individual, but the death involved co-ingestion of diphenhydramine at lethal levels, making it impossible to attribute the outcome to melatonin by itself. The same report noted that while a blood level of 1.4 mg/L has been published as potentially lethal in children, no equivalent threshold exists for adults.¹

A case report reviewing an attempted suicide by melatonin overdose concluded that melatonin is one of the least toxic medications available.² In animal toxicity studies, the doses needed to kill half the test population are extraordinarily high relative to any amount a person could plausibly consume, and those findings have never been replicated in a human context. The honest summary is that researchers have looked for a lethal dose in adults and have not found one, but the absence of evidence is not the same as proof of absolute safety.

What Actually Happens in an Overdose

If you swallow a very large amount of melatonin, you are far more likely to feel terrible than to be in medical danger. The most commonly reported symptoms of melatonin overdose include drowsiness, dizziness, fatigue, headache, confusion, nightmares, low blood pressure, rapid heart rate, and a drop in body temperature.² Most of these resolve as the body clears the hormone, which it does relatively quickly since melatonin’s half-life in the bloodstream is short.

The body-temperature drop is real and measurable, though modest at typical supplement doses. At doses between 1 and 5 mg, core body temperature falls by roughly a quarter to a third of a degree Celsius within about an hour. At 5 mg, the suppression persists longer than at smaller doses.³ The mechanism appears to involve increased heat loss through the skin, especially through the hands and feet. Research in younger and older women found that the degree of temperature drop correlated strongly with each person’s capacity to shed heat through the extremities, which explains why the effect varies so much from person to person.⁴ At normal supplement doses this temperature shift is trivial, but in theory, a massive overdose combined with environmental cold exposure could compound the risk. No documented case of hypothermia-related death from melatonin alone exists, but the physiological pathway is there.

Clinical Trials Using Doses Far Beyond the Bottle Label

One of the more striking pieces of evidence for melatonin’s safety comes from clinical settings where researchers deliberately gave people doses that dwarf anything on a supplement shelf. In a study of elderly patients with sleep disorders and other health conditions, daily melatonin doses ranged from 40 to 200 mg, with an average around 73 mg. More than half the patients stayed on treatment for over four years. No clinically significant side effects were observed; only occasional headache or dizziness turned up.⁵ To put that in perspective, a typical over-the-counter melatonin gummy contains somewhere between 1 and 10 mg. These patients were taking ten to twenty times as much, daily, for years.

A systematic review and meta-analysis that pooled data from higher-dose melatonin trials echoed this pattern: no detectable increase in serious adverse events or dropouts due to side effects, though mild issues like drowsiness, headache, and dizziness did come up more often in melatonin groups. The researchers noted that their confidence in the safety conclusion was limited by sparse reporting, and they called for better safety tracking in future long-term trials.⁶ So while the available data looks reassuring, it is also thinner than you might expect for something millions of people take nightly.

Why Children Face Greater Risk

The picture changes considerably for young children. Between 2012 and 2021, U.S. poison control centers received reports of over 260,000 pediatric melatonin ingestions. The annual number of cases rose by 530% over that period, and by 2021, melatonin accounted for about 5% of all pediatric ingestions reported to poison control, up from less than 1% in 2012. Five children required mechanical ventilation, and two died.⁷

Most of these cases involved young children under five who got hold of bottles of melatonin gummies, which look and taste like candy. The sheer increase in cases tracks with melatonin’s explosion in popularity as a household supplement. Children are more vulnerable for straightforward reasons: smaller body mass means any given dose is proportionally larger, and developing nervous systems respond differently to neurohormone flooding. The two deaths and the ventilator cases are a stark reminder that something being extremely safe for adults does not guarantee the same for a toddler who eats a handful of gummies.

The Labeling Problem Nobody Talks About

One complication that makes any melatonin safety discussion messier than it should be: the amount of melatonin in the bottle often has little resemblance to what the label claims. A study that tested a range of commercial melatonin products found actual melatonin content ranging from 83% less than the label stated to 478% more. Even different lots of the same product from the same manufacturer varied by as much as 465%.⁸

This means if you think you are taking 3 mg of melatonin, you could be taking anywhere from half a milligram to nearly 15 mg. For most adults, that variability is unlikely to cause anything worse than feeling groggier than expected the next morning. But for children, for people on medications that interact with melatonin, or for anyone trying to find their minimum effective dose, this is a genuine problem. Melatonin is regulated as a dietary supplement in the United States, which means manufacturers face far less scrutiny on dosing accuracy than pharmaceutical companies do. The lack of standardized quality control is one of the most practical risks associated with melatonin use, even though it has nothing to do with the hormone’s inherent toxicity.

Drug Interactions and Liver Stress

Where melatonin does carry real safety concerns is in its interactions with other medications. A clinical trial studying high-dose melatonin (the dose is not specified in the report’s extract, but the context is adjunctive therapy for multiple sclerosis) had to be stopped early because three out of four patients receiving melatonin developed elevated liver enzymes, a marker of liver stress. All affected patients were women taking multiple medications that share metabolic pathways with melatonin in the liver. The only male patient in the melatonin arm, who was not on those interacting drugs, had no liver problems over 14 months of treatment.⁹

The liver processes melatonin through the same enzyme pathways it uses for many common drugs, including certain blood pressure medications, antidepressants, and immunosuppressants. When melatonin floods these pathways at high doses, it can create a bottleneck that causes other drugs to accumulate to toxic levels, or that overwhelms the liver itself. This is where the “melatonin can’t kill you” framing gets dangerously oversimplified. Melatonin alone at high doses appears remarkably safe. Melatonin combined with certain drug regimens at high doses is a different question, and one that has already produced serious adverse events in a controlled trial setting.

Complicated Effects on Blood Pressure

Melatonin’s relationship with blood pressure is not as simple as “it lowers it” or “it raises it.” The direction of the effect depends on when you take it, what other medications you are using, and your baseline cardiovascular health. In healthy young adults eating a high-sodium diet, melatonin supplementation lowered nighttime blood pressure modestly without changing overall 24-hour averages.¹⁰ A separate study in men with high blood pressure found that a single dose of melatonin had no detectable effect on blood pressure at all.¹¹

But here is where it gets surprising: in patients already taking the calcium channel blocker nifedipine for hypertension, evening melatonin raised both blood pressure and heart rate over a 24-hour period, with systolic blood pressure climbing by an average of about 6.5 mmHg and heart rate increasing by about 4 beats per minute.¹² That is not a dangerous spike for most people, but for someone whose blood pressure is being carefully managed by medication, it is a meaningful and unwelcome shift. The takeaway is that melatonin’s cardiovascular effects are context-dependent, and anyone on blood pressure medication should mention melatonin use to their doctor rather than assuming it is too benign to matter.

Immune System Modulation

Melatonin does not just make you sleepy. It is an active modulator of the immune system, and at high doses, its immune effects become more pronounced. Research shows melatonin can shift the balance between different types of immune cells, influence inflammatory signaling, and act as both a pro-inflammatory and anti-inflammatory agent depending on the context.¹³ The pro-inflammatory side may help fight infections, but it can be a liability for anyone with an autoimmune condition.¹⁴

Research into melatonin’s effects on autoimmune diseases has shown benefit in several animal models, but the results for rheumatoid arthritis specifically have been less encouraging, and human data is still limited.¹⁵ For most healthy adults taking standard supplement doses, these immune effects are unlikely to cause noticeable problems. But for people with lupus, multiple sclerosis, rheumatoid arthritis, or other autoimmune conditions, high-dose melatonin is not the innocuous sleep aid it is marketed as. The immune modulation is real, and the direction it pushes depends on an individual’s existing immune landscape in ways that are not fully predictable.

Does Long-Term Use Shut Down Your Natural Production?

A common worry about taking melatonin regularly is that your body will stop making its own, leaving you dependent on the supplement to sleep. The available evidence suggests this fear is overblown. Research tracking urinary metabolites of melatonin in long-term users of prolonged-release melatonin found that endogenous production continued at normal rhythmic levels even after extended use. The natural nighttime rise in melatonin metabolites persisted, confirming that the body was still producing its own supply on schedule.¹⁶

This aligns with what researchers have observed more broadly: unlike some hormones where external supplementation triggers a feedback loop that suppresses internal production, melatonin does not appear to behave that way. Your pineal gland keeps doing its job. That said, most of this evidence comes from studies using pharmaceutical-grade prolonged-release formulations at standard doses. Whether the same holds true for people taking massive nightly doses of variable-quality gummies for years is a question that has not been rigorously answered.

Who Should Be Most Careful

The people for whom melatonin carries real, documented risk fall into a few groups. Young children are the most vulnerable population, both because accidental ingestions are rising sharply and because the physiological stakes are higher for a small body. Anyone taking multiple medications, especially drugs processed through the liver’s CYP1A2 enzyme pathway, should treat high-dose melatonin with genuine caution given the liver toxicity signals from the multiple sclerosis trial. People with autoimmune diseases should discuss melatonin use with their physician because of its capacity to shift immune activity in unpredictable directions. And people on calcium channel blockers for blood pressure should be aware that melatonin can partially counteract their medication.

For a healthy adult who takes a standard 1 to 5 mg dose at bedtime, the toxicological risk is about as low as it gets for any biologically active substance. The body produces melatonin endogenously every night, it clears the hormone rapidly, and even clinical doses orders of magnitude higher than what is sold in stores have failed to produce serious harm in monitored settings. The real dangers of melatonin have less to do with the molecule itself and more to do with the circumstances around it: children accessing unsecured bottles, drug interactions nobody warned you about, and labels that bear only a passing resemblance to what is inside the capsule.